Prot #TVTX-RE021-204: A Multicentered, Single-Group Phase 2, Exploratory, OpenLabel Study to Investigate Safety and Effect of Sparsentan in Combination with Sodium Glucose Cotransporter-2 (SGLT2) Inhibition in the Treatment of Adult Participants with Immu

  • Wadhwani, Shikha (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date2/27/242/27/27

Funding

  • George Clinical Pty Ltd. (Prot #TVTX-RE021-204 // Prot #TVTX-RE021-204)
  • Retrophin, Inc. (Prot #TVTX-RE021-204 // Prot #TVTX-RE021-204)